Mortality, hospitalisation, institutionalisation in community-dwelling oldest old: The impact of medication

Archives of Gerontology and Geriatrics

Volumn 65, Issue , 2016, Pages 9-16

  Wauters, Maarten ^a   Elseviers, Monique ^a   Vaes, Bert ^b,c   Degryse, Jan ^b,c   Vander Stichele, Robert ^a   Christiaens, Thierry ^a   Azermai, Majda ^a  

^a GHENT UNIVERSITY   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Aged, 80 and over; Drug utilization; Hospitalization; Institutionalization; Mortality; Primary health care

Indexed keywords

AGENTS AFFECTING LIPID METABOLISM; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; DIURETIC AGENT; LOOP DIURETIC AGENT; MINERAL; PSYCHOTROPIC AGENT; RESPIRATORY TRACT AGENT; VERAPAMIL;

AGED; ARTICLE; COMMUNITY LIVING; COMORBIDITY; DRUG USE; FEMALE; FUNCTIONAL STATUS; HOME CARE; HOSPITALIZATION; HUMAN; INDEPENDENT LIVING; INSTITUTIONALIZATION; LONGITUDINAL STUDY; MALE; MORTALITY; POLYPHARMACY; PRIORITY JOURNAL; SURVIVAL RATE; VERY ELDERLY; BELGIUM; EPIDEMIOLOGY; NURSING HOME; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AGED, 80 AND OVER; BELGIUM; FEMALE; HOSPITALIZATION; HUMANS; MALE; MORTALITY; NURSING HOMES; POLYPHARMACY; PROSPECTIVE STUDIES;

EID: 84958818076     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2016.02.009     Document Type: Article

References (35)

1. Alarcón T., Bárcena A., González-Montalvo J.I., Penãlosa C., Salgado A. Factors predictive of outcome on admission to an acute geriatric ward. Age and Ageing 1999, 28(5):429-432. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10529035.
2. Best O., Gnjidic D., Hilmer S.N., Naganathan V., McLachlan A.J. Investigating polypharmacy and drug burden index in hospitalised older people. Internal Medicine Journal 2013, 43(8):912-918. 10.1111/imj.12203.
3. Boeckxstaens P., Vaes B., Legrand D., Dalleur O., De Sutter A., Degryse J.-M. The relationship of multimorbidity with disability and frailty in the oldest patients: a cross-sectional analysis of three measures of multimorbidity in the BELFRAIL cohort. The European Journal of General Practice 2014, 1-6. 10.3109/13814788.2014.914167.
4. Carrasco-Garrido P., López de Andrés A., Hernández Barrera V., Jiménez-Trujillo I., Jiménez-García R. National trends (2003-2009) and factors related to psychotropic medication use in community-dwelling elderly population. International Psychogeriatrics/IPA 2013, 25(2):328-338. 10.1017/S104161021200169X.
5. Crimmins E.M. Trends in the health of the elderly. Annual Review of Public Health 2004, 25:79-98. 10.1146/annurev.publhealth.25.102802.124401.
6. Crum R.M. Population-based norms for the mini-mental state examination by age and educational level. JAMA: The Journal of the American Medical Association 1993, 269(18):2386. 10.1001/jama.1993.03500180078038.
7. Durán C.E., Azermai M., Vander Stichele R.H. Systematic review of anticholinergic risk scales in older adults. European Journal of Clinical Pharmacology 2013, 10.1007/s00228-013-1499-3.
8. Espino D.V., Bazaldua O.V., Palmer R.F., Mouton C.P., Parchman M.L., Miles T.P., et al. Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2006, 61(2):170-175. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16510861.
9. Fulton M.M., Allen E.R. Polypharmacy in the elderly: a literature review. Journal of the American Academy of Nurse Practitioners 2002, 17:132.
10. Gaugler J.E., Duval S., Anderson K.A., Kane R.L. Predicting nursing home admission in the U.S.: a meta-analysis. BMC Geriatrics 2007, 7:13. 10.1186/1471-2318-7-13.
11. Hajjar E.R., Cafiero A.C., Hanlon J.T. Polypharmacy in elderly patients. The American Journal of Geriatric Pharmacotherapy 2007, 5(4):345-351. 10.1016/j.amjopharm.2007.12.002.
12. Hanlon J.T., Schmader K.E., Ruby C.M., Weinberger M. Suboptimal prescribing in older inpatients and outpatients. Journal of the American Geriatrics Society 2001, 49:200-209. 10.1046/j.1532-5415.2001.49042.x.
13. Hanlon J.T., Fillenbaum G.G., Kuchibhatla M., Artz M.B., Boult C., Gross C.R., Schmader K.E. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Medical Care 2002, 40(2):166-176. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11802089.
14. Hilmer S.N., McLachlan A.J., Le Couteur D.G. Clinical pharmacology in the geriatric patient. Fundamental & Clinical Pharmacology 2007, 21(3):217-230. 10.1111/j.1472-8206.2007.00473.x.
15. Hudon C., Fortin M., Soubhi H. Abbreviated guidelines for scoring the Cumulative Illness Rating Scale (CIRS) in family practice. Journal of Clinical Epidemiology 2007, 60(2):212. 10.1016/j.jclinepi.2005.12.021.
16. Inouye S.K., Studenski S., Tinetti M.E., Kuchel G.A. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. Journal of the American Geriatrics Society 2007, 55(5):780-791. 10.1111/j.1532-5415.2007.01156.x.
17. Klarin I., Wimo A., Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs & Aging 2005, 22(1):69-82. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15663350.
18. Landi F., Cesari M., Onder G., Lattanzio F., Gravina E.M., Bernabei R. Physical activity and mortality in frail, community-living elderly patients. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2004, 59(8):M833-M837. 10.1093/gerona/59.8.M833.
19. Manesse C.K., Derkx F.H.M., De Ridder M.A.J., Man in't Veld A.J., van der Cammen T.J.M. Contribution of adverse drug reactions to hospital admission of older patients. Age and Ageing 2000, 29:35-39.
20. Meagher D.J. Regular review: delirium: optimising management. BMJ 2001, 322(7279):144-149. 10.1136/bmj.322.7279.144.
21. Miller M.D., Rifai A.H., Parrdis C.F., Wouck P.R., Stack J.A. Noit 1992, 237-248.
22. O'Mahony D., O'sullivan D., Byrne S., O'Connor M.N., Ryan C., Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age and Ageing 2014, 1-6. 10.1093/ageing/afu145.
23. Onder G., Vetrano D.L., Cherubini A., Fini M., Mannucci P.M., Marengoni A., Bernabei R. Prescription drug use among older adults in Italy: a country-wide perspective. Journal of the American Medical Directors Association 2014, 15(7):531. e11-5. 10.1016/j.jamda.2014.04.005.
24. Shi S., Mörike K., Klotz U. The clinical implications of ageing for rational drug therapy. European Journal of Clinical Pharmacology 2008, 64(2):183-199. 10.1007/s00228-007-0422-1.
25. Somers A., Robays H., Vander Stichele R., Van Maele G., Bogaert M., Petrovic M. Contribution of drug related problems to hospital admission in the elderly. The Journal of Nutrition, Health & Aging 2010, 14(6):477-482. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20617292.
26. Stevens J.A., Corso P.S., Finkelstein E.A., Miller T.R. The costs of fatal and non-fatal falls among older adults. Injury Prevention: Journal of the International Society for Child and Adolescent Injury Prevention 2006, 12(5):290-295. 10.1136/ip.2005.011015.
27. Strehblow C., Smeikal M., Fasching P. Polypharmacy and excessive polypharmacy in octogenarians and older acutely hospitalized patients. Wiener Klinische Wochenschrift 2014, 126(7-8):195-200. 10.1007/s00508-013-0485-1.
28. Sunaert P., Bastiaens H., Feyen L., Snauwaert B., Nobels F., Wens J., Willems S. Implementation of a program for type 2 diabetes based on the Chronic Care Model in a hospital-centered health care system: the Belgian experience. BMC Health Services Research 2009, 9(1):152. 10.1186/1472-6963-9-152.
29. Taipale H.T., Hartikainen S., Bell J.S. A comparison of four methods to quantify the cumulative effect of taking multiple drugs with sedative properties. The American Journal of Geriatric Pharmacotherapy 2010, 8(5):460-471. 10.1016/j.amjopharm.2010.10.004.
30. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society 2012, 60(4):616-631. 10.1111/j.1532-5415.2012.03923.x.
31. Tinetti M.E., Bogardus S.T., Agostini J.V. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. The New England Journal of Medicine 2004, 351(27):2870-2874. 10.1056/NEJMsb042458.
32. Vaes B., Pasquet A., Wallemacq P., Rezzoug N., Mekouar H., Olivier P.-A., Degryse J. The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium. BMC Geriatrics 2010, 10:39. 10.1186/1471-2318-10-39.
33. Veehof L.J.G., Stewart R.E., Haaijer-Ruskamp F.M., Meyboom-de Jong B. The development of polypharmacy. Family Practice 2000, 17(3):261-267.
34. Wauters M., Elseviers M., Vaes B., Degryse J., Dalleur O., Vander Stichele R., Azermai M. Polypharmacy in a Belgian cohort of community-dwelling oldest old (80+). Acta Clinica Belgica 2016, (submitted for publication). 10.1080/17843286.2016.1148298.
35. WHO (2016). The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD). Retrieved from . http://www.who.int/classifications/atcddd/en/.